In vivo, IHC revealed significant NCOA4 upregulation and FTH1 downregulation in SJS/TEN skin lesions relative to those in patients with EM or MPE and healthy individuals (Fig. S8). This evidence concerns the gene NCOA4 and erythema multiforme.